ICON Public Limited Company
ICLR
Ранг среди акций
#1606
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Цена акции
$174.32
Рыночная капитализация
$13.45B
Изменение (1 день)
3.68%
Изменение (1 год)
-7.50%
Страна
IE
Торговля ICON Public Limited Company (ICLR)
Категория
Healthcare
Коэффициент P/E для ICON Public Limited Company (ICLR)
Коэффициент P/E на October 2026 TTM: 39.38
Согласно последним финансовым отчетам и цене акций ICON Public Limited Company, текущий P/E (TTM) составляет 39.38. В конце 2023 у компании был P/E на уровне 37.95.
История P/E компании ICON Public Limited Company с 2001 по 2026
P/E на конец каждого года
| Год | P/E коэффициент | Изменить |
|---|---|---|
| 2026 (TTM) | 39.38 | 80.24% |
| 2024 | 21.85 | -42.42% |
| 2023 | 37.95 | 21.09% |
| 2022 | 31.34 | -76.90% |
| 2021 | 135.68 | 331.54% |
| 2020 | 31.44 | 26.76% |
| 2019 | 24.80 | 14.51% |
| 2018 | 21.66 | -1.60% |
| 2017 | 22.01 | 38.92% |
| 2016 | 15.85 | -16.84% |
| 2015 | 19.06 | 4.81% |
| 2014 | 18.18 | -24.06% |
| 2013 | 23.94 | -20.29% |
| 2012 | 30.04 | -33.47% |
| 2011 | 45.15 | 200.61% |
| 2010 | 15.02 | 11.16% |
| 2009 | 13.51 | -7.96% |
| 2008 | 14.68 | -7.47% |
| 2007 | 15.87 | 13.86% |
| 2006 | 13.93 | -38.57% |
| 2005 | 22.68 | 356.33% |
| 2004 | 4.97 | 12.27% |
| 2003 | 4.43 | -18.73% |
| 2002 | 5.45 | -20.05% |
| 2001 | 6.81 | 0.00% |
P/E для схожих компаний или конкурентов
| Компания | P/E Ratio | Разница P/E | Страна |
|---|---|---|---|
| 36.15 | -8.20% |
US
|
|
| 39.77 | 0.99% |
US
|
|
| -290.26 | -837.01% |
US
|
|
| - | - |
CN
|
|
| 34.18 | -13.20% |
US
|
Как читать P/E Ratio?
Коэффициент цена/прибыль (P/E Ratio) отражает соотношение между ценой акции компании и её прибылью на акцию.
Низкий, но положительный P/E говорит о том, что компания приносит высокую прибыль при низкой оценке и может быть недооценена. Высокий отрицательный (близкий к 0) P/E указывает на значительные убытки.
Компании с P/E выше 30 или отрицательным считаются "акциями роста" — инвесторы ожидают роста или будущей прибыли.
Компании с положительным P/E ниже 10 считаются "ценностными акциями", т.е. уже прибыльны, но с низким потенциалом роста.